Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
Sign Up to like & getrecommendations! Published in 2021 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2021.3671
Abstract: Importance Glial fibrillary acidic protein (GFAP) is a marker of reactive astrogliosis that increases in the cerebrospinal fluid (CSF) and blood of individuals with Alzheimer disease (AD). However, it is not known whether there are… read more here.
Keywords: mean; gfap levels; pathology; csf gfap ... See more keywords
Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack.
Sign Up to like & getrecommendations! Published in 2019 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2019.01.036
Abstract: OBJECTIVE Determination of glial fibrillary acidic protein (GFAP), aquaporin 4 (AQP4), and myelin oligodendrocyte glycoprotein (MOG) levels in cerebrospinal fluid (CSF), and astrocytic damage analysis in patients with GFAP astrocytopathy (GFAP-A) and other conditions. METHODS… read more here.
Keywords: csf gfap; astrocytopathy patients; gfap astrocytopathy; damage ... See more keywords
Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's disease
Sign Up to like & getrecommendations! Published in 2024 at "Clinical and Translational Science"
DOI: 10.1111/cts.70111
Abstract: Glial fibrillary acidic protein (GFAP) is an intermediate filament protein expressed mainly in astrocytes of the central nervous system (CNS), a potential biomarker of cognitive decline in Parkinson's disease (PD). The central motor subtypes of… read more here.
Keywords: cognition; csf gfap; progression; gfap ... See more keywords